|
August 5, 2010
Pharma major, Lupin Ltd on Tuesday announced the appointment of Mr Paul McGarty as the President of its US subsidiary, Lupin Pharmaceuticals.
McGarty has over 25 years experience in the pharmaceutical industry spanning across brand and specialty pharmaceutical companies, a press release issued here stated.
Most recently, as the CEO of Nycomed US, Mr McGarty successfully transformed the company from a topical manufacturer into a dermatology specialty company with a brand and generic business.
Under his leadership, Nycomed US emerged as a leading fully integrated dermatology specialty company in the US, the release said.
He has also served as a member of the Executive Committee and Board of Directors for the Generic Pharmaceutical Association (GPhA), as well as a member of the National Association of Chain Drug Stores (NACDS) Foundation Board, the release said.
“With more than 25 years of experience in pharmaceutical operations as well as commercial functions, in both generic and branded business, Paul brings invaluable experience and leadership skills to Lupin’s growth plans in the US,” Lupin Pharmaceuticals, Chief Executive Officer, Vinita Gupta, said |
Kaushik Suryakant Desai, chief executive officer & director, Global Pharmatech has been elected as chairman, Industrial Pharmacy Division and vice president of Indian Pharmaceutical Association (IPA) for the period 2010-12.
The Pharma Service Excellence Award for the year 2009 was honoured to Mr. Syed Abdul Kadir Barmawar, S/o late Dr. Syed Ahmed Barmawar. The Indian Pharmaceutical Professionals Council (IPPC) celebrated its annual get together which also coincided with the 7th National Pharmacy Week Celebrations at Hotel Holiday International, Sharjah on Friday, 18th December 2009.
